Resolved

ABRAXANE FOR INJECTABLE SUSPENSION

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ABRAXANE FOR INJECTABLE SUSPENSION in Canada?

Not currently. The most recent shortage report for ABRAXANE FOR INJECTABLE SUSPENSION 100MG is marked resolved (last updated July 8, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength100MG

Last updated2026-07-08

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02281066

Strength

100MG

Dosage Form

POWDER FOR SUSPENSION

Route

INTRAVENOUS

Active Ingredient

PACLITAXEL

Tier

Unrated

Last Updated

2026-07-08

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

15MG · DIN 02532573

5MG · DIN 02532557

2.5MG · DIN 02532549

10MG · DIN 02532565